Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 5/6 cls
Actelion (SWX:ATLN) Goldman Sachs Stephen McGarry Other Market outperform 2% CHF130.2
Nomura Sam Fazeli Upgrade Neutral (from reduce)
McGarry raised his FY05 and FY06 EPS estimates to CHF4.83 and CHF5.80 from CHF3.83 and CHF5.23. He also increased his FY05 revenue estimate to CHF606.2M ($513.1M) from CHF596.2M ($504.7M) to reflect his increased sales estimate for Tracleer. He now expects the pulmonary arterial hypertension drug to post FY05 sales of CHF587M ($496.8M),

Read the full 834 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers